CCL21 and gastric cancer: Shimakata et al. [7] investigated expression levels of a panel of solute carrier transporters (SLC) in AFPGC and conventional gastric cancer and proposed that patients with AFPGC may potentially benefit from gemcitabine/fluoropyrimidine combination chemotherapy.